QQQ   379.12 (+0.31%)
AAPL   149.32 (+0.46%)
MSFT   310.11 (+0.64%)
FB   315.81 (-3.92%)
GOOGL   2,786.17 (+1.35%)
TSLA   1,018.43 (-0.63%)
AMZN   3,376.07 (+1.68%)
NVDA   247.17 (+6.70%)
BABA   169.99 (-3.51%)
NIO   40.47 (-1.94%)
CGC   13.17 (-2.95%)
GE   107.44 (+2.03%)
AMD   122.93 (+0.47%)
MU   68.94 (+0.26%)
T   25.37 (-1.05%)
F   15.94 (-0.38%)
ACB   7.03 (-2.09%)
DIS   172.04 (+0.02%)
PFE   43.56 (+0.95%)
BA   209.81 (-1.44%)
AMC   36.05 (-2.12%)
QQQ   379.12 (+0.31%)
AAPL   149.32 (+0.46%)
MSFT   310.11 (+0.64%)
FB   315.81 (-3.92%)
GOOGL   2,786.17 (+1.35%)
TSLA   1,018.43 (-0.63%)
AMZN   3,376.07 (+1.68%)
NVDA   247.17 (+6.70%)
BABA   169.99 (-3.51%)
NIO   40.47 (-1.94%)
CGC   13.17 (-2.95%)
GE   107.44 (+2.03%)
AMD   122.93 (+0.47%)
MU   68.94 (+0.26%)
T   25.37 (-1.05%)
F   15.94 (-0.38%)
ACB   7.03 (-2.09%)
DIS   172.04 (+0.02%)
PFE   43.56 (+0.95%)
BA   209.81 (-1.44%)
AMC   36.05 (-2.12%)
QQQ   379.12 (+0.31%)
AAPL   149.32 (+0.46%)
MSFT   310.11 (+0.64%)
FB   315.81 (-3.92%)
GOOGL   2,786.17 (+1.35%)
TSLA   1,018.43 (-0.63%)
AMZN   3,376.07 (+1.68%)
NVDA   247.17 (+6.70%)
BABA   169.99 (-3.51%)
NIO   40.47 (-1.94%)
CGC   13.17 (-2.95%)
GE   107.44 (+2.03%)
AMD   122.93 (+0.47%)
MU   68.94 (+0.26%)
T   25.37 (-1.05%)
F   15.94 (-0.38%)
ACB   7.03 (-2.09%)
DIS   172.04 (+0.02%)
PFE   43.56 (+0.95%)
BA   209.81 (-1.44%)
AMC   36.05 (-2.12%)
QQQ   379.12 (+0.31%)
AAPL   149.32 (+0.46%)
MSFT   310.11 (+0.64%)
FB   315.81 (-3.92%)
GOOGL   2,786.17 (+1.35%)
TSLA   1,018.43 (-0.63%)
AMZN   3,376.07 (+1.68%)
NVDA   247.17 (+6.70%)
BABA   169.99 (-3.51%)
NIO   40.47 (-1.94%)
CGC   13.17 (-2.95%)
GE   107.44 (+2.03%)
AMD   122.93 (+0.47%)
MU   68.94 (+0.26%)
T   25.37 (-1.05%)
F   15.94 (-0.38%)
ACB   7.03 (-2.09%)
DIS   172.04 (+0.02%)
PFE   43.56 (+0.95%)
BA   209.81 (-1.44%)
AMC   36.05 (-2.12%)
OTCMKTS:WEDXF

The Westaim Stock Forecast, Price & News

$2.14
+0.03 (+1.55 %)
(As of 10/26/2021 01:44 PM ET)
Add
Compare
Today's Range
$2.11
$2.14
50-Day Range
$1.90
$2.16
52-Week Range
$1.75
$2.36
Volume13,977 shs
Average Volume35,706 shs
Market Capitalization$306.11 million
P/E Ratio53.46
Dividend YieldN/A
Beta0.68
30 days | 90 days | 365 days | Advanced Chart
Receive WEDXF News and Ratings via Email

Sign-up to receive the latest news and ratings for The Westaim and its competitors with MarketBeat's FREE daily newsletter.


The Westaim logo

About The Westaim

The Westaim Corp. engages in the provision of long-term capital to businesses operating primarily within the global financial services industry. The firm invests, directly and indirectly, through acquisitions, joint ventures, and other arrangements. Its investments include Skyward Specialty and Arena. The Skyward Specialty segment is a U.S. based property & casualty diversified specialty insurance company group providing coverage primarily in the United States but also globally for certain risks. The Arena segment consists of two separate businesses, namely Arena Investors and Arena FINCOs. The Arena Investors including AI, an investment manager making fundamentals-based, asset-oriented credit investments on behalf of third-party investors; The Arena FINCOs, include specialty finance companies that primarily purchase fundamentals-based, asset oriented credit investments for their own account. The company was founded on May 7, 1996 and is headquartered in Toronto, Canada.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
OTCMKTS:WEDXF
Employees
7
Year Founded
N/A

Sales & Book Value

Annual Sales
$24.85 million
Cash Flow
$0.04 per share
Book Value
$2.24 per share

Profitability

Net Income
$-34.40 million

Debt

Price-To-Earnings

Miscellaneous

Market Cap
$306.11 million
Next Earnings Date
11/11/2021 (Estimated)
Optionable
Not Optionable

MarketRank

Overall MarketRank

1.76 out of 5 stars

Analyst Opinion: 3.5Community Rank: 4.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -












The Westaim (OTCMKTS:WEDXF) Frequently Asked Questions

Is The Westaim a buy right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for The Westaim in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" The Westaim stock.
View analyst ratings for The Westaim
or view top-rated stocks.

What stocks does MarketBeat like better than The Westaim?

Wall Street analysts have given The Westaim a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but The Westaim wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting The Westaim?

The Westaim saw a decline in short interest in September. As of September 30th, there was short interest totaling 24,300 shares, a decline of 50.0% from the September 15th total of 48,600 shares. Based on an average daily volume of 41,100 shares, the short-interest ratio is currently 0.6 days.
View The Westaim's Short Interest
.

When is The Westaim's next earnings date?

The Westaim is scheduled to release its next quarterly earnings announcement on Thursday, November 11th 2021.
View our earnings forecast for The Westaim
.

How were The Westaim's earnings last quarter?

The Westaim Co. (OTCMKTS:WEDXF) issued its quarterly earnings data on Thursday, August, 19th. The company reported $0.08 earnings per share for the quarter, topping analysts' consensus estimates of $0.06 by $0.02. The company earned $0.57 million during the quarter. The Westaim had a trailing twelve-month return on equity of 7.91% and a net margin of 265.70%.
View The Westaim's earnings history
.

How has The Westaim's stock been impacted by COVID-19?

The Westaim's stock was trading at $1.4808 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, WEDXF stock has increased by 44.4% and is now trading at $2.1378.
View which stocks have been most impacted by COVID-19
.

What price target have analysts set for WEDXF?

1 equities research analysts have issued 12-month target prices for The Westaim's stock. Their forecasts range from $4.15 to $4.15. On average, they anticipate The Westaim's stock price to reach $4.15 in the next year. This suggests a possible upside of 94.1% from the stock's current price.
View analysts' price targets for The Westaim
or view top-rated stocks among Wall Street analysts.

Who are The Westaim's key executives?

The Westaim's management team includes the following people:
  • John Cameron MacDonald, President, Chief Executive Officer & Director
  • Robert Terrance Kittel, Chief Operating Officer
  • Glenn Garry MacNeil, Chief Financial Officer

What is The Westaim's stock symbol?

The Westaim trades on the OTCMKTS under the ticker symbol "WEDXF."

How do I buy shares of The Westaim?

Shares of WEDXF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is The Westaim's stock price today?

One share of WEDXF stock can currently be purchased for approximately $2.14.

How much money does The Westaim make?

The Westaim has a market capitalization of $306.11 million and generates $24.85 million in revenue each year.

How many employees does The Westaim have?

The Westaim employs 7 workers across the globe.

What is The Westaim's official website?

The official website for The Westaim is www.westaim.com.

Where are The Westaim's headquarters?

The Westaim is headquartered at 70 York Street Suite 1700, Toronto A6, M5J 1S9.

How can I contact The Westaim?

The Westaim's mailing address is 70 York Street Suite 1700, Toronto A6, M5J 1S9. The company can be reached via phone at (416) 969-3333 or via email at [email protected].


This page was last updated on 10/26/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.